BRIEF published on 08/29/2025 at 07:00, 3 months 7 days ago Recticel's Solid First-Half 2025 Performance in Challenging Markets Revenue Growth Financial Performance Recticel Investment Plans Insulation Market
REGULATED PRESS RELEASE published on 08/29/2025 at 06:55, 3 months 7 days ago Recticel Once Again Outperforming Markets Recticel Group announces strong first-half 2025 results, with sales up by 12.3% and Adjusted EBITDA growing 10.4%. Strategic investments on track. FY 2025 outlook positive Adjusted EBITDA Sales Growth Strategic Investments Recticel Group First-half 2025 Results
BRIEF published on 06/30/2025 at 18:05, 5 months 4 days ago Recticel Increases Capital via Subscription Rights Exercise Recticel Capital Increase Shares Issuance Euronext Brussels Subscription Rights
REGULATED PRESS RELEASE published on 06/30/2025 at 18:00, 5 months 4 days ago Capital increase through exercise of subscription rights Recticel announces capital increase through exercise of subscription rights resulting in the issuance of 30,000 new ordinary shares. Shares to be traded on Euronext Brussels starting 2 July 2025 Recticel Financial Calendar Capital Increase Euronext Brussels Subscription Rights
BRIEF published on 05/27/2025 at 15:05, 6 months 8 days ago Recticel Annual and Extraordinary General Meetings Resolutions Dividend Announcement Director Appointments Auditor Appointment Recticel Resolutions General Meetings Outcome
REGULATED PRESS RELEASE published on 05/27/2025 at 15:00, 6 months 8 days ago Resolutions of Ordinary and Extraordinary General Meeting Recticel's Annual Shareholders' Meeting 2025 approves dividend of EUR 0.31 per share, appoints new directors, and sets financial targets for emissions reduction Recticel Dividend Shareholders' Meeting Emissions Reduction Directors
BRIEF published on 04/29/2025 at 07:02, 7 months 6 days ago Recticel Reports 12.7% Increase in Q1 2025 Sales European Market Recticel Growth Outlook Insulation Boards Q1 2025 Sales
REGULATED PRESS RELEASE published on 04/29/2025 at 06:57, 7 months 6 days ago Recticel Trading update first quarter 2025 Recticel reports 12.7% increase in net organic sales in Q1 2025. Strong residential sector activity boosts Insulation Boards business growth Recticel Residential Sector Organic Sales Q1 2025 Insulation Boards
BRIEF published on 04/24/2025 at 18:05, 7 months 10 days ago Recticel Announces Capital Increase Through Subscription Rights Share Capital Recticel Capital Increase Euronext Brussels Subscription Rights
REGULATED PRESS RELEASE published on 04/24/2025 at 18:00, 7 months 10 days ago Capital increase through exercise of subscription rights Recticel announces capital increase through exercise of subscription rights resulting in issuance of 45,000 new shares. Company offers smart insulation solutions promoting carbon-free economy Recticel Capital Increase Euronext Brussels Subscription Rights Insulation Solutions
Published on 12/05/2025 at 02:35, 5 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 3 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
